Sussman MA - Search Results

1

Prevention of cardiac hypertrophy in mice by calcineurin inhibition.

Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Sussman MA, et al. Science. 1998 Sep 11;281(5383):1690-3. doi: 10.1126/science.281.5383.1690. Science. 1998. PMID: 9733519

2

Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice.

Sussman MA, Welch S, Gude N, Khoury PR, Daniels SR, Kirkpatrick D, Walsh RA, Price RL, Lim HW, Molkentin JD. Sussman MA, et al. Am J Pathol. 1999 Dec;155(6):2101-13. doi: 10.1016/S0002-9440(10)65528-9. Am J Pathol. 1999. PMID: 10595939 Free PMC article.

3

Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice.

Sussman MA, Welch S, Walker A, Klevitsky R, Hewett TE, Witt SA, Kimball TR, Price R, Lim HW, Molkentin JD. Sussman MA, et al. Cardiovasc Res. 2000 Apr;46(1):90-101. doi: 10.1016/s0008-6363(99)00422-8. Cardiovasc Res. 2000. PMID: 10727657

4

Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.

Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD. Lim HW, et al. Among authors: sussman ma. J Mol Cell Cardiol. 2000 Apr;32(4):697-709. doi: 10.1006/jmcc.2000.1113. J Mol Cell Cardiol. 2000. PMID: 10756124

5

Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production.

Sayen MR, Gustafsson AB, Sussman MA, Molkentin JD, Gottlieb RA. Sayen MR, et al. Among authors: sussman ma. Am J Physiol Cell Physiol. 2003 Feb;284(2):C562-70. doi: 10.1152/ajpcell.00336.2002. Epub 2002 Oct 23. Am J Physiol Cell Physiol. 2003. PMID: 12397029 Free article.

6

Notch signaling and cardiac repair.

Gude N, Sussman M. Gude N, et al. J Mol Cell Cardiol. 2012 Jun;52(6):1226-32. doi: 10.1016/j.yjmcc.2012.03.007. Epub 2012 Mar 21. J Mol Cell Cardiol. 2012. PMID: 22465038 Free PMC article. Review.

7

Cardiac regenerative therapy: Many paths to repair.

Gude NA, Sussman MA. Gude NA, et al. Among authors: sussman ma. Trends Cardiovasc Med. 2020 Aug;30(6):338-343. doi: 10.1016/j.tcm.2019.08.009. Epub 2019 Sep 2. Trends Cardiovasc Med. 2020. PMID: 31515053 Free PMC article. Review.

8

Re-evaluating sarcoplasmic reticulum function in heart failure.

Delling U, Sussman MA, Molkentin JD. Delling U, et al. Among authors: sussman ma. Nat Med. 2000 Sep;6(9):942-3. doi: 10.1038/79592. Nat Med. 2000. PMID: 10973288 No abstract available.

9

Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice.

Welch S, Plank D, Witt S, Glascock B, Schaefer E, Chimenti S, Andreoli AM, Limana F, Leri A, Kajstura J, Anversa P, Sussman MA. Welch S, et al. Among authors: sussman ma. Circ Res. 2002 Apr 5;90(6):641-8. doi: 10.1161/01.res.0000013780.77774.75. Circ Res. 2002. PMID: 11934830

10

Fibronectin contributes to pathological cardiac hypertrophy but not physiological growth.

Konstandin MH, Völkers M, Collins B, Quijada P, Quintana M, De La Torre A, Ormachea L, Din S, Gude N, Toko H, Sussman MA. Konstandin MH, et al. Among authors: sussman ma. Basic Res Cardiol. 2013 Sep;108(5):375. doi: 10.1007/s00395-013-0375-8. Epub 2013 Aug 4. Basic Res Cardiol. 2013. PMID: 23912225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters